Twin Focus Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Twin Focus Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,054	Closed	-$274K	–	137
2024 Q1	$274K	Sell	5,054 -400	-7%	-$20.4K	0.05%	122
2023 Q4	$280K	Buy	5,454 +180	+3%	+$9.45K	0.06%	125
2023 Q3	$306K	Sell	5,274 -3,098	-37%	-$190K	0.07%	118
2023 Q2	$535K	Buy	8,372 +2,566	+44%	+$172K	0.11%	107
2023 Q1	$402K	Buy	5,806 +51	+0.9%	+$3.6K	0.08%	124
2022 Q4	$414K	Buy	5,755 +41	+0.7%	+$3.09K	0.09%	116
2022 Q3	$406K	Hold	5,714	–	–	0.1%	107
2022 Q2	$440K	Hold	5,714	–	–	0.1%	110
2022 Q1	$417K	Buy	5,714 +130	+2%	+$8.73K	0.08%	130
2021 Q4	$348K	Buy	5,584 +1,022	+22%	+$60K	0.07%	147
2021 Q3	$270K	Buy	4,562 +44	+1%	+$2.9K	0.06%	146
2021 Q2	$302K	Buy	+4,518	New	+$295K	0.07%	138
2021 Q1	–	Sell	-3,717	Closed	-$231K	–	164
2020 Q4	$231K	Buy	+3,717	New	+$229K	0.07%	140
2020 Q2	–	Sell	-7,795	Closed	-$434K	–	150
2020 Q1	$434K	Buy	7,795 +104	+1%	+$6.36K	0.2%	75
2019 Q4	$494K	Buy	7,691 +1,985	+35%	+$114K	0.16%	102
2019 Q3	$289K	Buy	+5,706	New	+$268K	0.11%	110

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Twin Focus Capital Partners's BMY Position: Q2 2024 in Review

Twin Focus Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 5,054 shares — an estimated $274K sold.

Twin Focus Capital Partners first reported a position in BMY in Q3 2019 and held it in 16 quarters. The position peaked at $535K in Q2 2023. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Twin Focus Capital Partners reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Twin Focus Capital Partners sold 5,054 Bristol-Myers Squibb shares in Q2 2024, an estimated $274K.
Twin Focus Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 16 quarters.
Twin Focus Capital Partners's Bristol-Myers Squibb position peaked at $535K in Q2 2023.
2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Twin Focus Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.